BOTHELL, Wash.-- EKOS Corporation announced today the EKOS EkoSonic® Endovascular System is the first endovascular device approved for the treatment of pulmonary embolism (PE). The EkoSonic® System, ...
LONDON--(BUSINESS WIRE)--BTG plc (LSE: BTG), the global healthcare company, announced today that the first EKOS™ CU 4.0 units have been shipped from BTG’s facility in Bothell (Washington, US) to ...
BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation, a privately held medical device company located in Bothell, Washington, announced the results of DUET, the world’s first and only multi-center ...
The danger in someone with the condition of deep vein thrombosis is that a portion of a blood clot that predominately forms in the leg could break off and travel to the patient’s lungs causing a ...
MARLBOROUGH, Mass. -- Boston Scientific Corporation has commenced enrollment in the HI-PEITHO clinical trial, a collaborative research study with the Pulmonary Embolism Response Team (PERT) Consortium ...
Boston Scientific, a Marlborough-based biomedical life sciences firm, is using electronic health records from 80 million U.S. patients to inform a new study into pulmonary embolism. PE is a ...
NORWALK -- Norwalk Hospital is in the forefront in the treatment of deep venous thrombosis (DVT), a serious and potentially life threatening condition that occurs when a blood clot forms in one of the ...
His doctor says a device that's revolutionizing the way he attacks clots may have saved the patient's life. Two and a half feet! That's how big the blood clot was in Gerry Cunha's body. "I just couldn ...
A new angiographic service has been launched which uses mechanical and chemical techniques to break down blood clots that block the major arteries of the lungs. This was announced by the Minister for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback